State-of-the-Art Review: Hepatitis C.

Vincent Lo Re, Debika Bhattacharya, Jennifer C Price, Andrew Aronsohn, H Nina Kim, Oluwaseun Falade-Nwulia, Matty Zimmerman, Stacey Trooskin, Jessie Torgersen

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025;81(2):e15-e26

PMID: 40971900

Abstract

Hepatitis C virus (HCV) infection remains a major cause of chronic liver disease and premature mortality worldwide. The World Health Organization and US Department of Health and Human Services have committed to eliminating HCV infection as a major public health threat by 2030, as defined by a 90% reduction in incidence of new HCV infections and 65% reduction in mortality from a 2015 baseline. To help to achieve HCV elimination, it will be necessary to increase HCV screening and increase uptake of HCV treatment, particularly within primary care, correctional, and substance use treatment settings. In this review, we provide strategies for healthcare providers to implement in their practice to enhance patients' completion of the steps of the HCV care cascade. Improving successful completion of each step of the cascade will help alleviate the burden of HCV infection and make the 2030 HCV elimination goals a reality.

© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].

Address: Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago Illinois, USA.; Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.; Department of Pharmacy, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, USA.; Executive Medical Officer, Mazzoni Center, Philadelphia, Pennsylvania, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.